Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.

Jeffrey Montgomery

Concepts (437)

Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Urinary Bladder Neoplasms
54
2026
167
9.280
Why?
Cystectomy
32
2025
52
5.910
Why?
Prostatic Neoplasms
43
2024
401
4.640
Why?
Kidney Neoplasms
22
2018
181
2.510
Why?
Carcinoma, Transitional Cell
13
2023
54
2.430
Why?
Prostatectomy
22
2023
84
2.130
Why?
Nephrectomy
19
2016
81
1.810
Why?
Lymph Node Excision
7
2024
132
1.660
Why?
Urinary Diversion
6
2021
43
1.480
Why?
Laparoscopy
13
2014
180
1.400
Why?
Prostate
14
2024
118
1.400
Why?
Quality of Life
13
2025
902
1.350
Why?
Aged
82
2025
10430
1.220
Why?
Male
121
2025
27444
1.140
Why?
Humans
151
2026
53246
1.090
Why?
Middle Aged
88
2025
13422
1.090
Why?
Neoadjuvant Therapy
12
2024
124
1.030
Why?
Neoplasm Staging
26
2026
774
0.980
Why?
BCG Vaccine
7
2024
16
0.880
Why?
Robotics
8
2015
43
0.870
Why?
Postoperative Complications
15
2021
1099
0.840
Why?
Neoplasm Recurrence, Local
16
2025
647
0.830
Why?
Retrospective Studies
52
2024
6821
0.830
Why?
Carcinoma, Renal Cell
10
2016
112
0.820
Why?
Penile Neoplasms
3
2024
45
0.800
Why?
Ureter
3
2016
35
0.740
Why?
Exercise Therapy
1
2023
105
0.740
Why?
Exercise
2
2023
561
0.720
Why?
Hernia
2
2020
6
0.700
Why?
Treatment Outcome
31
2025
5597
0.660
Why?
Intestine, Small
2
2020
114
0.650
Why?
Medical Oncology
5
2026
97
0.630
Why?
Aged, 80 and over
27
2025
3495
0.620
Why?
Physical Fitness
1
2020
56
0.620
Why?
Herniorrhaphy
1
2020
33
0.620
Why?
Intestinal Obstruction
1
2020
38
0.620
Why?
Patient Readmission
6
2021
251
0.600
Why?
Neoplasm Invasiveness
15
2025
281
0.600
Why?
Image-Guided Biopsy
6
2024
36
0.590
Why?
Watchful Waiting
7
2019
29
0.580
Why?
Biopsy
17
2023
600
0.560
Why?
Ureteral Neoplasms
2
2018
11
0.550
Why?
Female
60
2025
28792
0.530
Why?
Organ Sparing Treatments
5
2025
58
0.510
Why?
Testicular Neoplasms
4
2024
46
0.500
Why?
Magnetic Resonance Imaging
10
2023
1587
0.500
Why?
Urinary Bladder
7
2018
101
0.490
Why?
Prospective Studies
18
2025
2412
0.490
Why?
Convalescence
1
2016
6
0.490
Why?
Carcinoma, Squamous Cell
4
2024
332
0.480
Why?
Neoplasm Grading
14
2025
128
0.470
Why?
Neoplasms, Germ Cell and Embryonal
3
2024
21
0.460
Why?
Urothelium
4
2018
20
0.440
Why?
Carcinoma in Situ
4
2024
72
0.440
Why?
Chemotherapy, Adjuvant
8
2024
122
0.430
Why?
Ileum
1
2014
88
0.420
Why?
Urologic Neoplasms
3
2019
12
0.420
Why?
Choline
3
2019
64
0.410
Why?
Quality Indicators, Health Care
1
2013
92
0.370
Why?
Needles
3
2021
25
0.360
Why?
Administration, Intravesical
7
2024
16
0.350
Why?
Urologic Surgical Procedures
3
2016
30
0.350
Why?
Disease Progression
8
2024
880
0.350
Why?
Lymphatic Metastasis
4
2024
211
0.350
Why?
Antineoplastic Agents
3
2021
1232
0.350
Why?
Survival Rate
9
2021
949
0.340
Why?
Biopsy, Needle
5
2021
181
0.340
Why?
Prostate-Specific Antigen
8
2021
43
0.340
Why?
Testicular Diseases
1
2011
9
0.330
Why?
Risk Assessment
10
2019
1368
0.330
Why?
Tumor Burden
6
2016
132
0.320
Why?
Urogenital Neoplasms
1
2010
9
0.320
Why?
Magnetic Resonance Imaging, Interventional
4
2024
5
0.320
Why?
Muscle Neoplasms
1
2010
17
0.320
Why?
Registries
4
2023
652
0.300
Why?
Antineoplastic Combined Chemotherapy Protocols
4
2024
1043
0.300
Why?
Fluorine Radioisotopes
2
2019
25
0.300
Why?
Retroperitoneal Space
5
2016
26
0.300
Why?
Recovery of Function
2
2023
203
0.300
Why?
Adult
27
2024
14541
0.290
Why?
Psoas Muscles
2
2021
2
0.290
Why?
Self Report
1
2010
225
0.290
Why?
Telomerase
2
2019
26
0.280
Why?
Patient Selection
5
2019
273
0.270
Why?
Urinary Incontinence
3
2023
40
0.270
Why?
Deoxycytidine
3
2024
26
0.260
Why?
Seat Belts
2
2017
17
0.260
Why?
Child Restraint Systems
2
2017
18
0.260
Why?
Urinary Catheterization
1
2007
24
0.260
Why?
Positron-Emission Tomography
2
2019
299
0.260
Why?
Urethral Stricture
1
2007
23
0.260
Why?
Time Factors
13
2020
2992
0.260
Why?
Rectum
2
2024
55
0.250
Why?
Primary Health Care
1
2011
404
0.250
Why?
Cohort Studies
8
2021
1557
0.250
Why?
Tomography, X-Ray Computed
3
2021
1183
0.250
Why?
Guideline Adherence
3
2017
143
0.240
Why?
Length of Stay
6
2020
684
0.240
Why?
Health Status
2
2015
306
0.230
Why?
Patient Discharge
3
2017
325
0.230
Why?
Pain Measurement
2
2017
259
0.230
Why?
Kidney
4
2014
717
0.220
Why?
Patient Participation
2
2016
72
0.220
Why?
Carcinoma
2
2018
136
0.220
Why?
Bandages
1
2005
28
0.220
Why?
Adenoviridae
2
2024
46
0.220
Why?
Surgical Wound Infection
1
2005
118
0.220
Why?
Neurilemmoma
1
2004
25
0.210
Why?
Age Factors
7
2021
1136
0.210
Why?
Adenocarcinoma
3
2016
405
0.210
Why?
Immunohistochemistry
5
2024
975
0.210
Why?
Multivariate Analysis
8
2016
598
0.210
Why?
Antimetabolites, Antineoplastic
1
2024
39
0.210
Why?
Quality Improvement
3
2016
230
0.210
Why?
Organoids
1
2024
41
0.210
Why?
Venous Thrombosis
1
2005
91
0.210
Why?
Follow-Up Studies
9
2024
2318
0.200
Why?
Perineum
1
2024
26
0.200
Why?
Antibiotic Prophylaxis
1
2024
65
0.200
Why?
Decision Making
2
2016
278
0.200
Why?
Clinical Competence
3
2016
406
0.190
Why?
Practice Guidelines as Topic
2
2018
502
0.190
Why?
Prognosis
9
2021
2118
0.180
Why?
Urethra
3
2014
98
0.180
Why?
Erectile Dysfunction
3
2023
94
0.180
Why?
United States
12
2020
5413
0.180
Why?
DNA, Neoplasm
2
2018
146
0.180
Why?
Logistic Models
7
2021
947
0.170
Why?
Feasibility Studies
2
2020
412
0.170
Why?
Vital Statistics
1
2021
3
0.170
Why?
Mandatory Reporting
1
2021
11
0.170
Why?
DNA Mutational Analysis
3
2018
179
0.170
Why?
Death Certificates
1
2021
17
0.170
Why?
Cost-Benefit Analysis
2
2019
274
0.170
Why?
Birth Certificates
1
2021
26
0.170
Why?
Cell Transdifferentiation
1
2021
8
0.170
Why?
Reproducibility of Results
7
2018
1221
0.170
Why?
Neuroendocrine Cells
1
2021
9
0.170
Why?
Urethral Diseases
2
2013
7
0.160
Why?
Radiosurgery
1
2022
133
0.160
Why?
Mutation
5
2019
1338
0.160
Why?
Radiography, Abdominal
1
2020
25
0.160
Why?
Reimbursement, Incentive
1
2020
12
0.160
Why?
Genetic Vectors
1
2020
127
0.160
Why?
Randomized Controlled Trials as Topic
4
2023
630
0.150
Why?
Ablation Techniques
1
2019
19
0.150
Why?
Genetic Therapy
1
2020
127
0.150
Why?
Abdominal Pain
1
2020
84
0.150
Why?
Diagnosis, Differential
2
2020
1038
0.150
Why?
Genetic Predisposition to Disease
5
2024
533
0.150
Why?
Venous Thromboembolism
1
2020
78
0.150
Why?
Adjuvants, Immunologic
3
2024
52
0.140
Why?
Urinary Tract
1
2018
24
0.140
Why?
Predictive Value of Tests
6
2018
933
0.140
Why?
Lymphocytes
1
2019
146
0.140
Why?
Forecasting
1
2019
152
0.140
Why?
Obesity
2
2006
1205
0.140
Why?
Patient-Centered Care
1
2020
141
0.140
Why?
Genetic Heterogeneity
1
2018
20
0.140
Why?
RNA, Neoplasm
1
2018
45
0.140
Why?
Neutrophils
1
2019
153
0.140
Why?
Internship and Residency
2
2021
439
0.140
Why?
Programmed Cell Death 1 Receptor
1
2018
46
0.140
Why?
Drug Resistance, Neoplasm
1
2020
350
0.140
Why?
Retroperitoneal Neoplasms
1
2018
17
0.130
Why?
Orchiectomy
1
2018
38
0.130
Why?
Transurethral Resection of Prostate
1
2018
10
0.130
Why?
Pain, Postoperative
2
2016
169
0.130
Why?
Body Size
1
2017
33
0.130
Why?
Quality Assurance, Health Care
1
2018
146
0.130
Why?
Physician-Patient Relations
2
2016
146
0.130
Why?
Inguinal Canal
1
2017
11
0.130
Why?
Urodynamics
2
2014
24
0.130
Why?
Sarcosine
1
2017
3
0.130
Why?
Databases, Factual
2
2021
742
0.130
Why?
Amino Acid Transport Systems
1
2017
5
0.130
Why?
Anticoagulants
1
2020
280
0.130
Why?
Body Height
1
2017
68
0.130
Why?
Safety
1
2017
78
0.130
Why?
Guidelines as Topic
1
2017
111
0.130
Why?
Carbon Radioisotopes
1
2017
55
0.130
Why?
Electronic Health Records
1
2020
287
0.120
Why?
Disease-Free Survival
5
2016
466
0.120
Why?
Transcriptome
2
2018
368
0.120
Why?
Replantation
1
2016
11
0.120
Why?
Scrotum
2
2015
31
0.120
Why?
Protons
1
2017
75
0.120
Why?
Nomograms
1
2016
8
0.120
Why?
Laparotomy
1
2016
37
0.120
Why?
Natural Orifice Endoscopic Surgery
1
2016
6
0.120
Why?
Physicians
2
2016
242
0.120
Why?
Research Report
1
2016
19
0.120
Why?
Kaplan-Meier Estimate
5
2017
487
0.120
Why?
Urinary Retention
2
2007
7
0.120
Why?
Patient Preference
1
2016
44
0.120
Why?
Ureteral Obstruction
1
2016
62
0.120
Why?
Checklist
1
2016
40
0.110
Why?
Preoperative Period
3
2021
47
0.110
Why?
Time-to-Treatment
1
2016
81
0.110
Why?
Sensitivity and Specificity
5
2018
869
0.110
Why?
Genital Neoplasms, Male
1
2015
3
0.110
Why?
Body Weight
1
2017
524
0.110
Why?
Paget Disease, Extramammary
1
2015
6
0.110
Why?
Lymph Nodes
1
2017
252
0.110
Why?
Social Networking
1
2015
19
0.110
Why?
Radiopharmaceuticals
1
2016
198
0.110
Why?
Feedback
1
2015
53
0.110
Why?
Treatment Failure
2
2017
119
0.110
Why?
Video Recording
1
2015
81
0.110
Why?
Informed Consent
1
2015
94
0.110
Why?
Peer Group
1
2015
63
0.110
Why?
Proto-Oncogene Proteins B-raf
1
2015
78
0.110
Why?
Papilloma, Inverted
1
2014
1
0.110
Why?
Equipment Design
3
2021
290
0.110
Why?
Proto-Oncogene Proteins p21(ras)
1
2014
69
0.100
Why?
Computer Simulation
1
2015
290
0.100
Why?
Blood Loss, Surgical
5
2016
66
0.100
Why?
Matched-Pair Analysis
1
2013
11
0.100
Why?
Urinary Incontinence, Stress
1
2014
32
0.100
Why?
Kidney Diseases
1
2016
230
0.100
Why?
Adenoma
1
2015
114
0.100
Why?
Diffusion of Innovation
1
2013
47
0.100
Why?
Carcinoma, Papillary
1
2014
50
0.100
Why?
Body Mass Index
3
2020
717
0.100
Why?
General Surgery
1
2015
108
0.100
Why?
Technology Transfer
1
2013
2
0.100
Why?
Mitomycin
1
2013
19
0.100
Why?
Longitudinal Studies
2
2018
774
0.100
Why?
Radiotherapy, Adjuvant
2
2018
65
0.090
Why?
Accreditation
1
2013
63
0.090
Why?
Severity of Illness Index
2
2014
1049
0.090
Why?
Peripheral Nerves
1
2013
43
0.090
Why?
Education, Medical, Continuing
1
2013
76
0.090
Why?
Operating Rooms
1
2012
27
0.090
Why?
Pathology, Clinical
1
2012
25
0.090
Why?
Referral and Consultation
2
2012
299
0.090
Why?
Community Health Centers
1
2012
33
0.090
Why?
Receptors, Androgen
2
2002
48
0.090
Why?
Algorithms
1
2015
668
0.090
Why?
Combined Modality Therapy
3
2021
640
0.090
Why?
Neoplasms
1
2021
1335
0.080
Why?
Risk Factors
5
2017
4018
0.080
Why?
Perioperative Care
1
2011
44
0.080
Why?
Seminal Vesicles
2
2022
13
0.080
Why?
Skin Neoplasms
1
2015
500
0.080
Why?
Phantoms, Imaging
2
2020
113
0.080
Why?
Medicare
3
2020
280
0.070
Why?
Multicenter Studies as Topic
2
2023
114
0.070
Why?
Proportional Hazards Models
3
2016
445
0.070
Why?
Markov Chains
2
2019
28
0.070
Why?
Carboplatin
2
2022
57
0.070
Why?
SEER Program
3
2014
106
0.070
Why?
Immunotherapy
1
2010
266
0.070
Why?
Postoperative Care
2
2020
109
0.070
Why?
Healthcare Disparities
1
2011
312
0.070
Why?
Ureteroscopy
1
2007
10
0.070
Why?
Pandemics
2
2023
595
0.070
Why?
Automobiles
2
2017
13
0.070
Why?
Sarcopenia
2
2021
100
0.070
Why?
Incidence
2
2021
1085
0.070
Why?
Chi-Square Distribution
3
2013
291
0.070
Why?
Diverticulum
1
2007
21
0.070
Why?
Peritoneum
1
2007
16
0.060
Why?
Cisplatin
2
2022
282
0.060
Why?
Delphi Technique
2
2018
71
0.060
Why?
Gene Amplification
2
2018
58
0.060
Why?
Aftercare
2
2018
73
0.060
Why?
Societies, Medical
2
2018
207
0.060
Why?
Gene Expression Profiling
2
2024
1112
0.060
Why?
Adrenalectomy
1
2006
31
0.060
Why?
Promoter Regions, Genetic
2
2019
465
0.060
Why?
Postoperative Hemorrhage
1
2006
54
0.060
Why?
Case-Control Studies
3
2014
1212
0.060
Why?
Fibrin Tissue Adhesive
1
2005
13
0.060
Why?
Sex Factors
2
2020
747
0.060
Why?
Hand
1
2005
50
0.060
Why?
Tissue Adhesives
1
2005
15
0.060
Why?
Genomics
2
2018
271
0.060
Why?
Intestines
1
2006
159
0.060
Why?
Suture Techniques
1
2005
57
0.050
Why?
Renal Insufficiency
1
2005
108
0.050
Why?
Diabetes Complications
1
2005
124
0.050
Why?
Chromosomes, Human, Pair 12
1
2024
14
0.050
Why?
Glomerular Filtration Rate
2
2016
128
0.050
Why?
Drug Screening Assays, Antitumor
1
2024
136
0.050
Why?
Superior Mesenteric Artery Syndrome
1
2004
3
0.050
Why?
Mediastinal Neoplasms
1
2024
19
0.050
Why?
Vulnerable Populations
1
2024
54
0.050
Why?
Communication
2
2016
263
0.050
Why?
Intraoperative Complications
1
2005
114
0.050
Why?
Phenotype
2
2018
803
0.050
Why?
Hernia, Inguinal
1
2004
22
0.050
Why?
High-Throughput Nucleotide Sequencing
2
2015
181
0.050
Why?
Cell Line, Tumor
2
2018
1470
0.050
Why?
Neoplasms, Second Primary
1
2024
75
0.050
Why?
Child
3
2024
7384
0.050
Why?
Quality of Health Care
2
2015
189
0.050
Why?
Ischemia
1
2004
158
0.050
Why?
Papillomavirus Infections
2
2015
177
0.050
Why?
Perioperative Period
2
2013
21
0.050
Why?
Trinucleotide Repeats
1
2002
3
0.050
Why?
Liver Cirrhosis
1
2005
246
0.050
Why?
Chromosome Aberrations
1
2024
297
0.050
Why?
Muscles
1
2022
110
0.050
Why?
Odds Ratio
2
2014
567
0.040
Why?
Smoking
1
2005
526
0.040
Why?
Polymorphism, Restriction Fragment Length
1
2002
65
0.040
Why?
Accidents, Traffic
2
2017
91
0.040
Why?
Gallium Isotopes
1
2021
2
0.040
Why?
Radiotherapy, Intensity-Modulated
2
2013
181
0.040
Why?
Gallium Radioisotopes
1
2021
9
0.040
Why?
Edetic Acid
1
2021
14
0.040
Why?
Geography
1
2021
65
0.040
Why?
Androgen Antagonists
1
2021
13
0.040
Why?
Polymorphism, Single Nucleotide
1
2024
505
0.040
Why?
Quarantine
1
2021
11
0.040
Why?
Public Health
1
2023
231
0.040
Why?
Internationality
1
2021
46
0.040
Why?
Neoplasm Metastasis
2
2017
237
0.040
Why?
Motion
1
2020
16
0.040
Why?
Drug Dosage Calculations
1
2020
11
0.040
Why?
Enoxaparin
1
2020
32
0.040
Why?
Finite Element Analysis
1
2020
11
0.040
Why?
Fellowships and Scholarships
1
2021
124
0.040
Why?
Drug Monitoring
1
2020
81
0.040
Why?
Pelvis
1
2020
66
0.040
Why?
Abdomen
1
2020
71
0.040
Why?
DNA-Directed RNA Polymerases
1
2019
11
0.040
Why?
Heparin
1
2020
86
0.040
Why?
Young Adult
2
2024
4514
0.040
Why?
Postoperative Period
1
2020
169
0.040
Why?
Social Behavior
1
2019
74
0.040
Why?
Urine
1
2018
26
0.040
Why?
Cytodiagnosis
1
2018
42
0.040
Why?
Adolescent
2
2024
6912
0.040
Why?
Diagnostic Errors
1
2018
68
0.030
Why?
Single-Blind Method
1
2018
120
0.030
Why?
Image Processing, Computer-Assisted
1
2019
235
0.030
Why?
DNA Copy Number Variations
1
2018
117
0.030
Why?
Genome, Human
1
2018
121
0.030
Why?
Quality-Adjusted Life Years
1
2018
67
0.030
Why?
Sequence Analysis, RNA
1
2018
97
0.030
Why?
Random Allocation
1
2018
284
0.030
Why?
Hospitalization
2
2017
749
0.030
Why?
Delivery of Health Care, Integrated
1
2018
61
0.030
Why?
Health Services Accessibility
2
2012
477
0.030
Why?
Dose-Response Relationship, Drug
1
2020
1367
0.030
Why?
Nephrons
1
2016
6
0.030
Why?
Tissue Distribution
1
2017
174
0.030
Why?
Consensus
1
2018
206
0.030
Why?
Hospital Communication Systems
1
2016
5
0.030
Why?
Coitus
1
2016
18
0.030
Why?
Failure to Thrive
1
2016
19
0.030
Why?
Salvage Therapy
1
2017
138
0.030
Why?
Anastomosis, Surgical
1
2016
69
0.030
Why?
Radiometry
1
2017
125
0.030
Why?
Creatinine
1
2016
158
0.030
Why?
Molecular Imaging
1
2016
28
0.030
Why?
Early Detection of Cancer
1
2018
190
0.030
Why?
Cyclin-Dependent Kinase 4
1
2015
10
0.030
Why?
Multiplex Polymerase Chain Reaction
1
2015
12
0.030
Why?
Operative Time
1
2016
78
0.030
Why?
Genes, erbB-1
1
2015
9
0.030
Why?
Tape Recording
1
2015
7
0.030
Why?
Fever
1
2016
112
0.030
Why?
Socioeconomic Factors
2
2011
623
0.030
Why?
Learning Curve
1
2015
20
0.030
Why?
Groin
1
2015
16
0.030
Why?
Tissue Array Analysis
1
2015
45
0.030
Why?
Oncology Service, Hospital
1
2014
14
0.030
Why?
Clinical Trials, Phase III as Topic
1
2015
48
0.030
Why?
Vinblastine
1
2014
22
0.030
Why?
Europe
1
2014
91
0.030
Why?
Regression Analysis
1
2015
391
0.030
Why?
North America
1
2014
75
0.030
Why?
Incontinence Pads
1
2014
2
0.030
Why?
In Situ Hybridization
1
2014
69
0.030
Why?
Kidney Failure, Chronic
1
2016
210
0.030
Why?
Amino Acid Substitution
1
2014
79
0.030
Why?
Gene Expression Regulation, Neoplastic
1
2018
868
0.030
Why?
Personal Satisfaction
1
2014
76
0.030
Why?
Gene Dosage
1
2014
76
0.030
Why?
Ultrasonography
1
2016
426
0.030
Why?
Methotrexate
1
2014
78
0.030
Why?
United States Department of Veterans Affairs
1
2015
295
0.030
Why?
Papillomaviridae
1
2014
104
0.030
Why?
Survivors
1
2014
120
0.030
Why?
Anxiety
1
2016
321
0.020
Why?
Dysuria
1
2013
1
0.020
Why?
Anesthesiology
1
2014
37
0.020
Why?
Cluster Analysis
1
2014
238
0.020
Why?
Sequence Analysis, DNA
1
2014
216
0.020
Why?
Prevalence
1
2016
1034
0.020
Why?
Intention to Treat Analysis
1
2013
30
0.020
Why?
Valsalva Maneuver
1
2013
10
0.020
Why?
Stents
1
2016
376
0.020
Why?
Diagnostic Tests, Routine
1
2013
31
0.020
Why?
Health Services Research
1
2013
153
0.020
Why?
Paclitaxel
1
2013
91
0.020
Why?
Doxorubicin
1
2014
248
0.020
Why?
Confidence Intervals
1
2013
158
0.020
Why?
Neutropenia
1
2013
113
0.020
Why?
Antibiotics, Antineoplastic
1
2013
84
0.020
Why?
Survival Analysis
1
2014
659
0.020
Why?
Thrombocytopenia
1
2013
89
0.020
Why?
Attitude of Health Personnel
1
2015
371
0.020
Why?
Angiomyolipoma
1
2012
9
0.020
Why?
Unnecessary Procedures
1
2012
20
0.020
Why?
Neoplasm, Residual
1
2013
171
0.020
Why?
Tertiary Care Centers
1
2012
86
0.020
Why?
Pilot Projects
1
2014
727
0.020
Why?
Neoplasms, Multiple Primary
1
2012
44
0.020
Why?
Biopsy, Fine-Needle
1
2012
104
0.020
Why?
Patient Positioning
1
2011
31
0.020
Why?
Urination Disorders
1
2010
23
0.020
Why?
Disease Management
1
2012
187
0.020
Why?
Organ Size
1
2010
228
0.020
Why?
Comorbidity
1
2012
638
0.020
Why?
Health Status Disparities
1
2011
221
0.020
Why?
Intraoperative Period
1
2007
46
0.020
Why?
Erythrocyte Transfusion
1
2006
53
0.020
Why?
Costs and Cost Analysis
1
2006
93
0.010
Why?
Decision Trees
1
2005
23
0.010
Why?
Portal System
1
2005
17
0.010
Why?
Collateral Circulation
1
2005
39
0.010
Why?
Hypertension, Portal
1
2005
23
0.010
Why?
Reoperation
1
2006
476
0.010
Why?
Blood Transfusion
1
2005
127
0.010
Why?
Short Bowel Syndrome
1
2004
17
0.010
Why?
Necrosis
1
2004
169
0.010
Why?
Liver Transplantation
1
2005
174
0.010
Why?
Polymorphism, Genetic
1
2002
181
0.010
Why?
Genetic Markers
1
2002
104
0.010
Why?
Statistics, Nonparametric
1
2002
198
0.010
Why?
Base Sequence
1
2002
620
0.010
Why?
Polymerase Chain Reaction
1
2002
452
0.010
Why?
Molecular Sequence Data
1
2002
759
0.010
Why?
Montgomery's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description